Opposition Brief — Montemayor, Commissioner, Texas Department of Insurance v. Corporate Health Insurance
Supreme Court brief2002
Ask Donna
What actually matters in this document.
Text
FIL FE
~-
yea
No. 00-665 | Ci!
Sepreme Court. US.
DEC § 2000
IN THE
Supreme Court of the United States
JOSE MONTEMAYOR, COMMISSIONER OF THE TEXAS
DEPARTMENT OF INSURANCE; JOHN CORNYN,
ATTORNEY GENERAL OF TEXAS,
Petitioners,
Vv.
CORPORATE HEALTH INSURANCE, INC.; AETNA HEALTH
PLANS OF TEXAS, INC.; AETNA HEALTH PLANS OF
NORTH TEXAS, INC.; AETNA LIFE INSURANCE
COMPANY,
Respondents.
On Petition For A Writ Of Certiorari
To The United States Court of Appeais
for the Fifth Circuit
RESPONDENTS’ BRIEF IN CPPOSITION
JOHN B. SHELY MIGUEL A. ESTRADA
KENDALL M. GRAY Counsel of Record
_ ANDREWS & KURTH LLP RACHEL A. CLARK
600 Travis, Suite 4200 GIBSON, DUNN & CRUTCHER LLP
Houston, Texas 77002 1050 Connecticut Avenue, N.W.
(713) 220-4200 Washington, D.C. 20036
(202) 955-8500
Counsel for Respondents
ep?
eee
34
hid
QUESTIONS PRESENTED
1. Whether the Employee Retirement Income Secu-
rity Act of 1974, 29 U.S.C. § 1001 et seg., preempts the
independent review requirements established by Texas
Senate Bill 386.
2. Whether the Federal Employees Health Benefit
Act, 5 U.S.C. § 8901 et seg., preempts the independent
review requirements established by Texas Senate Bill
386.
il
PARTIES TO THE PROCEEDING AND RULE 29.6
STATEMENT
The caption contains the names of all of the parties to
the proceeding. All respondents are indirect subsidiaries
or affiliates of Aetna, Inc., a publicly traded company. .
il]
TABLE OF CONTENTS
Page
QUESTIONS PRESENTED ........ccccscccsscsccossssrsssessessneses 1
PARTIES TO THE PROCEEDING AND RULE
BE TE INS 0 senercssnssnsesccnssonssnssnesesasssasincncecsconcncegen il
Te Gi PART SIREN BEBO scescesscnscceccnssnsessannsevensccacccce 1V
CIEE MEME IE OU sccsscicsensovibscsosnssosaseansccosssoressesennnsates ]
IIIT TIE scccsckstiarissiesasssissconrsstnanenssnsicneosecsooseseasees
CONSTITUTIONAL AND STATUTORY
PROVISIONS INVOLVED ........cccccccrsccccccscccsccsscsvecseess ]
STATEMENT............... Taso cada snelasideaenacecnpaniinh l
PEIEIEIIIEITUT schsnctssensusdsissanncnssossseecnsserebesnncsaswegeancceseeannecs 6
I. THIS CASE DOES NOT PROPERLY
PRESENT THE ISSUE WHETHER
STATE STATUTES THAT CONFLICT
WITH THE EXCLUSIVE REMEDIES
SET FORTH IN SECTION 502 ARE
SAVED FROM PREEMPTION BY
ERISA’S “SAVING CLAUSE.”..........:cscssceee 7
II. TEXAS’ STATUTE IS CLEARLY
PREEMPTED BY ERISA BECAUSE IT
CONFLICTS WITH SECTION 502 AND
IS NOT SAVED FROM SECTION 514
IIE BRIM: sasncenrscnsaiccnsacsscensinsnscesnesorseccsene 14
III. TEXAS HAS FAILED TO IDENTIFY
ANY REASON WARRANTING
REVIEW OF THE FIFTH CIRCUIT’S
PA PERRIER s cennesnsccsnsacssnssnsacsacsnenecsssnancces 25
Be II cccinimnsnrinscssenoncensennsonenasercennonmasconsanssnssnne 26
1V
TABLE OF AUTHORITIES
Page(s)
CASES
Alessi v. Raybestos-Manhattan, Inc., 451
ES Ry 5 RRR Tiapeeece Ney Grae EDR NEED Artec ePaha 15
Boggs v. Boggs, 520 U.S. 833 (1997)... eeeeees 8,17
California Div. of Labor Standards
Enforcement v. Dillingham Constr., N.A.,
ee ee ee I Bsc taccaiecndicdsb an cacheuiaiininisasiniteisaatetn 15
Donatelli v. Home Insurance Co., 992 F.2d
Fa I ililidichitiiesp ii biasantecioniaieanitonstentsinie 23
E.I. du Pont de Nemours & Co. v. Train, 430
ns eae He ouiiiaciasiecicindaiandess elles asibucsisascentlanesnbtipiinaiks 23
FMC Corp. v. Holliday, 498 U.S. 52 (1990)............ 19, 20
Fort Halifax Packing Co. v. Coyne, 482 U.S.
ID visu citiehdosensen:tiedpbecilieaclataraclnaselaaasastinauicasehanlattiactine 16, 17
Garcia v. Texas State Bd. of Med.
Examiners, 384 F. Supp. 434 (W.D. Tex.
ND7E), OG, SE1 UB, FOS CAST) savncsccssntentansnsonssznes 18
In re U.S. Healthcare, Inc., 193 F.3d 151
(3d Cir. 1999), cert. denied, 120 S. Ct.
Ne CU iaidisatiennCinsickecslaannseisledmnibiahdenantidguatccinneinnninns 12
In re Life Ins. Co. of N. Am., 857 F.2d 1190
Cs SI iin nieksssanies Kerteiniinidesiaiciandiiesieiinenans eakaaess 9
Jun v. Lloyds, No. 03-00-00110-CV, 2000 WL
1675683 (Tex. App.-Austin, Nov. 9, 2000)............... 22
Vv
Metropolitan Life Ins. Co. v. Massachusetts,
OTE ee TE CE kininase passim
Metropolitan Life Ins. v. Taylor, 481 U.S. 58
OC RIIIET P scctssicsadinasdaccinasiaticcsiiamintiobamen de cakecmmdiamall 12
Moran v. Rush Prudential HMO, Inc., 230
Fe er CF eel Bist aieiisastsdenianatanannaniann passim
New York State Conference of Blue Cross &
Blue Shield Plans v. Travelers Ins. Co.,
SISELS, GS CFS initiate 15
PAS v. Travelers Ins. Co., 7 F.3d 349 (3d
Ct. BIE cincccnossinecieasenengensemeaasnala 11, 12,22
Patterson v. McLean Credit Union, 491 U.S. -
BG CE cinccnsncscmsintctandespenidaaaamaninee 10
Pegram vy. Herdrich, 120 S. Ct. 2143
CD iiscscsnrsccnniisanissccnmbiienimademaaaaannen 6, 17,23
Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41
CEDIE FD inicsccinsciachiesmnitiieesniteacaiaaadaaaaiaamie nae passim
Ramirez v. Intercontinental Hotels, 890 F.2d 760
(Si Oe, RII rcistcancutinscstescssetarnmaionaaenaiancinen 13
Rivet v. Regions Bank of Louisiana, 522
CLS. S70 Ci atinsicssicnemmannianianainen 12
Ruble v. UNUM Life Insurance Co. of Am.,
DiS FBG Bae COA, FOO iiccietieerecniiinniion a3
Shaw v. Delta Air Lines, Inc., 463 U.S. 85
CUSED sccicitsisnisitnindespbiasicticippaniicoleaseiaeadiaaa manmade 16
Thompson v. General Health Systems, Inc.,
202 FS VOTE CR CA, FI ccaiiessanestccennioniictnnemenntntct 16
vi
Union Labor Life Ins. Co. v. Pireno, 458
UB. LED CEI ccrsssicscensescesaeasaaaaneeal 20
United States v. Mendoza, 464 U.S. 154
( FIDE) scnnsnnstsinitnnenseessainpiapenanannadimamecmaaiaaladaaama 23
United States v. Williams, 504 U.S. 36
( SIPUUE ) asccarsecinseiapinniuabeunmmalasamaddenanmenm ame 13
UNUM Life Ins. Co. v. Ward, 526 U.S. 358
(TDS P .cinschscsnnecienstenbemmeapaninmmenaaaiaa 4,9, 18,19
Williams Ins. Trust v. Travelers Ins. Co., 50
eee Te Ce | nes 11, 15, 16, 24
STATUTES
> UDA. § GPG! 68 AOE, cinta i ie
> UA. © GENIC 8 P casscnssinssiuiteeinmeiiancacame naan 25
> UDG. & Gal dusnsctssesccssoaansiceanaeaaaaaeee 25
5S U.BA.. § 5085 OC OU, sccsisieananenenaee 18
1S UB. & BG1Z.csicctiscstonscsetssita aia 5
a0 UBA.. § TED) cccienenimaaeee ]
29 CFR. FUR SI0e ninintienimaiaeneae 24
29 CPR. POR ZIGG. De Ue sahiccisesnseccnesasieicasnniie 24
9 UD As. | TGG8 GEOR cnntisicecicceeeanae ie
29 UB. § WOR inssiutcentneanaenaaee 16
29 Uda. | W6aRcitiniiennninncicdcaaaee ae i
29 Uke. | LED venice 6, 7
29 USA. | TESA cncsvsiseictnimceaiaenenns 5
39 UBS. © Poi iicccrcimectunaaaaanan 7,15
20 UBS. § TAR cccauicetetnnaaaeeen . passim
Vil
29 U.S.C. § 1144(b)(2)(A)...cccccccccscscsesesessseseeeeesees 4,7,8,9
BE ee ET > mene 19
TEX. INS. CODE ANN. arts. 20A.09.cccccccsscsssesssescsesssssseee 2
TEX. INS. CODE ANN. arts. 20A.12A.0........ccccccsccsssesesseeees 2
TEX. INS. CODE ANN. art. 21.58A
Pe Petes asiscuscaceseioaidadsiiuatananmeumacuacisnadenctal 2
TEX. INS. CODE ANN. art. 21.58A § 2(2).....cccccccceseseseeseeee 2
RIK, BGR. COMM ARO, Wit, 20 TBA. vcccessnccieninssccesssicssecenionns 2
TEX. INS. CODE ANN. art. 21.58A § 2(17)(B)............ 2,19
TEX. INS. CODE ANN. art. 21.58A § 2(17)(C)............ 2,19
TEX. INS. CODE ANN. art. 21.58A
Sy Fane a ssivinibacdainicseadaadadapmianidaindaandataaiiiamadtamismaaeaias 2
TEX. INS. CODE ANN. art. 21.58A § 2(21)(B)............ 2,19
TEX. INS. CODE ANN. art. 21.58A § 2(21)(C).............20005- 2
TEX. INS. CODE ANN. art. 21.58A § 6 ...ccccscccssseeseeee. 2,19
TEX. INS. CODE ANN. art. 21.58A § 6A ...............cse0 2,19
Vill
OTHER AUTHORITIES
Fe I LT cencicnssesccsccnsnnnnesnsstanensonnaen 6, 25
Pees A, DUN ONE, CRD IGD cncnceccncncscssnsnnsnsacnncasossence 24
Peis Pig WUD GIR, CID ccccscicsnnsneasscnnnsnantennnenancson 24
is Se, I A I ai cincshcconnictssencanscdnenehiestinigeanns 24
S.Amend. 3694, 106th Cong. (2000)... eee 24
BNA’s Health Care Daily Report, Plan
Regulation: Bill of Rights Could Make
CI Oe I II Srccssccsscsnsactncrncrnisncosnscnssnes 24
Business Groups Prepare, Bureau of Na-
tional Affairs, Inc. (Dec. 6, 2000) ...............ceeeeeee eens 24
OPINIONS BELOW
The opinions of the court of appeals (Pet. App. Al-
A26, D1-D8) are reported at 215 F.3d 526 (Sth Cir.
2000) and 220 F.3d 641 (Sth Cir. 2000), respectively.
The opinion of the district court (Pet. App. B1-B82) is
reported at 12 F. Supp. 2d 597 (S.D. Tex. 1998).
JURISDICTION
The judgment of the court of appeals was entered on
June 20, 2000. A petition for panel rehearing was de-
nied on July 27, 2000. Pet. App. Di, D6. The petition
for a writ of certiorari was filed on October 24, 2000.
The jurisdiction of this Court is invoked under 28 U.S.C.
§ 1254(1).
CONSTITUTIONAL AND STATUTORY
PROVISIONS INVOLVED
Texas’ Senate Bill 386, the Supremacy Clause of the
United States Constitution and the pertinent provisions
of the Employee Retirement Income Security Act of
1974, 29 U.S.C. § 1001 et seg. and the Federal Employ-
ees Health Benefit Act, 5 U.S.C. § 8901 et seq. are re-
produced in the appendix to this brief.
STATEMENT
1. In 1997, Texas enacted Senate Bill 386 (“SB
386”). The law purports to subject managed care or-
ganizations (“MCOs”) to a set of independent review
requirements through which members may appeal ad-
verse determinations of medical necessity made by an
MCO. Specifically, SB 386 applies to any “preferred
provider organization” (“PPO”), “health maintenance
organization” (“HMO”), or “any other person or entity
which provides * * * or administers * * * health benefits
* * * pursuant to a policy, plan, or contract.” TEX. INS.
2
CODE ANN. art. 21.58A §§ 2(17)(B) and (C), 2(21)(B), 6
and 6A (West 1999).! The Texas statute requires MCOs
to fund an independent review by a state-approved or-
ganization (“independent review organization” or
“TRO”) whenever an MCO’s utilization review agent
denies a plan enrollee’s appeal of an adverse coverage
determination. TEX. INS. CODE ANN. arts. 20A.09,
20A.12A, & 21.58A (West 1999); Pet. App. E1-E2, E4,
E6-E7. In addition, the state provisions mandate that
MCOs must “comply” with the IRO’s determination of
the “medical necessity” or “appropriateness” of the par-
ticular health care coverage at issue. Id. at E5.2
1 SB 386 applies by its terms to insurers writing health in-
surance policies, to self-insured plans, employers with em-
ployees in Texas who are covered under a health benefit plan
or health insurance policy, and administrators as defined by
article 21.07-6 of Texas Insurance Code. TEX. INS. CODE
ANN. art. 21.58A §§ 2(2), 2(17)(A) and (B), 2(21)(A), (B)
and (C), 6, and 6A (West 1999). While Section 14(e) of Ar-
ticle 21.58A purports to exempt ERISA plans from the IRO
provisions, Texas nevertheless sought to apply them both to
ERISA plans and to entities that administer benefits on be-
half of those plans. Appearing as amicus in support of Texas
in the courts below, the Secretary of Labor called the mean-
ing of Section 14(e) “uncertain” under state law, and there-
fore characterized federal review as “premature.” See Brief
of Secretary of Labor as Amicus Curiae 23-27 (Sth Cir. Mar.
12, 1999).
2 The validity of the law’s other provisions—which purport
to establish liability for MCOs that fail to meet an “ordinary
care” standard (“the liability provisions”) and to prohibit
MCOs from including indemnification clauses in their con-
tracts and from retaliating against doctors or health care pro-
viders for advocating health care coverage (“the anti-
indemnification and anti-retaliation provisions”)—is not at
issue before this Court. Even so, the court of appeals did not
hold, as Texas implies, that one might use SB 386 (or any
[Footnote continued on next page]
Saale ede. BBL MI ADL ee ENR A Aaa a ay Re REA MRL Ie aK EN Pe oe Ok 2
3
2. Respondents—several indirect wholly-owned
subsidiaries of Aetna, Inc.—are MCOs that are subject
to SB 386’s independent review provisions. Respondent
Aetna Life Insurance Company, for example, makes
coverage determinations for employee benefit plans
(both insured and self-funded) governed by ERISA. See
Record at 20:72-75. The petitioners are Jose Monte-
mayor, Commissioner of the Texas Department of In-
surance, and John Cornyn, Attorney General of Texas
(collectively “Texas”).
After SB 386 was enacted, respondents (hereinafter
“Aetna’’) filed suit against Texas in federal district court,
seeking declaratory and injunctive relief. With respect
to the issues pertinent here, Aetna asserted that the Em-
ployee Retirement Income Security Act of 1974
(“ERISA”), 29 U.S.C. § 1001 et seg., and the Federal
Employees Health Benefit Act (“FEHBA”), 5 U.S.C.
§ 8901 et seg., preempt the Texas statute’s independent
review provisions.
On cross-motions for summary judgment, the dis-
trict court ruled, in pertinent part, that ERISA preempts
the IRO provisions of SB 386. First, the court held that
ERISA’s express preemption provision, ERISA
§ 514(a), 29 U.S.C. § 1144(a), preempts the independent
review provisions because they would “improperly
mandate the administration of employee benefits” and
would interfere with “the goal of uniformity [in ERISA
[Footnote continued from previous page}
other state law theory) to sue an MCO for improper benefits
determinations, based on medical necessity or otherwise. In
order to conclude that the liability provisions are not neces-
sarily preempted in all of their applications, the court of ap-
peals construed those provisions as applying only to a “lim-
ited universe of events,” namely vicarious liability claims
arising from the professional malpractice of a treating physi-
cian. See, e.g., Pet. A8-A9.
4
plan regulation] that Congress sought to implement”
through Section 514(a). Pet. App. B66-B67 (citation
omitted). The court next concluded that SB 386 is not a
state law regulating insurance under ERISA’s saving
clause, ERISA § 514(b)(2)(a); 29 U.S.C.
§ 1144(b)(2)(A). The court reasoned that, “on its face,
the Act is obviously not ‘limited to entities within the
insurance industry.’ Even though the Act lists health
insurance carriers as one group covered by its terms, it
also specifies that it applies to health maintenance or-
ganizations and other managed care entities for a health
care plan.” Pet. App. B15 (quoting Metropolitan Life
Ins. Co. v. Massachusetts, 471 U.S. 724, 743 (1985)).3
With respect to Aetna’s claim that SB 386 also cre-
ates an impermissible alternate enforcement mecha-
nisms, the court concluded that courts should determine
on a case-by-case basis “[w]hether a claim seeks review
of an adverse benefit determination [which would re-
quire preemption] or to secure quality coverage [which
would not].” Jd. at B76-B77. The court reached a simi-
lar conclusion on Aetna’s claim that FEHBA preempts
SB 386. /d. at B80. Having determined, however, that
SB 386’s independent review provisions are preempted
by ERISA’s express preemption provision and not saved
under the saving clause, the court severed the IRO pro-
visions from the remainder of the bill. /d. at B67-B68.
3 Because the district court ruled on the preemption ques-
tion before this Court decided UNUM Life Ins. Co. of Am. v.
Ward, 526 U.S. 358 (1999), the court relied on Fifth Circuit
precedent that required that a state regulation must satisfy all
three McCarran-Ferguson factors in order to be viewed as a
regulation of insurance under ERISA’s saving clause. After
determining that SB 386 failed the third factor because it is
not limited to entities within the insurance industry, the dis-
trict court thus had no occasion to analyze the other factors.
Cr Sec Oe et is cers ec ne. tr Weare ot Senet Ener. tis
3. The court of appeals affirmed in part and re-
versed in part, concluding in pertinent part that ERISA
and FEHBA preempt the independent review provisions
of SB 386. Pet. App. Al-A26.
The court first held that Texas’ IRO provisions fall
squarely within the scope of ERISA’s express preemp-
tion provision: “The [independent review] provisions
allow a patient who has been denied coverage to appeal
to an outside organization. Such an attempt to impose a
state administrative regime governing coverage determi-
nations is squarely within the ambit of ERISA’s preemp-
tive reach.” Pet. App. Al3. The court then held that
ERISA’s saving clause does not save the IRO provisions
from preemption. Pet. App. Al3-A16. The court first
noted that the independent review provisions meet two
of three factors for identifying the business of insurance
under the McCarran Ferguson Act, 15 U.S.C. § 1012:
although those provisions “probably do not * * * reallo-
cat[e] * * * risk,” they are aimed at insurers and regulate
the insured-insurer relationship. Jd. at Al3-Al4. The
court noted, however, that the McCarran-Ferguson fac-
tors are not the end of the analysis under ERISA’s sav-
ing clause, because Pilot Life Ins. Co. v. Dedeaux, 481
U.S. 41 (1987), held that the clause does not save state
laws that conflict with Section 502(a) of ERISA, 29
U.S.C. § 1132(a). Pet. App. A15.
The court explained that the independent review
procedures conflict with Section 502(a) because they
bind ERISA plans to the decisions of IROs regarding
whether benefits must be paid, and “create[] an alterna-
tive mechanism through which plan members may seek
benefits due them under the terms of the plan—the iden-
tical relief offered under § 1132(a)(1)(B) of ERISA.”
Pet. App. at A15-Al16. The court therefore held that
Texas’ independent review provisions “conflict with
ERISA’s exclusive remedy and cannot be saved by the
savings clause.” Jd. at Al6.
6
Finally, the court of appeals determined that
FEHBA preempts the independent review provisions
under general conflict principles because those provi-
sions conflict with the administrative remedy concerning
benefits disputes provided by the Office of Personnel
Management under FEHBA. Pet. App. Al7 (citing 5
U.S.C. § 8902()); 5 C.F.R. § 890.105-890.107). Having
found the independent review provisions preempted, the
court then severed them from the remainder of the stat-
ute.
4. Texas sought rehearing of the panel’s ruling that
ERISA and FEHBA preempt SB 386’s IRO provisions,
contending that that ruling was contrary to Pegram v.
Herdrich, 120 S. Ct. 2143 (2000). The court denied re-
hearing, but it issued a supplemental opinion rejecting
Texas’ reliance on Pegram. The court explained that
Pegram held that mixed eligibility and treatment deci-
sions made by an HMO through its physicians are not
fiduciary acts under ERISA, but that Pegram did not
“entail that every conceivable state law survives pre-
emption so long as it is based on a mixed question of
eligibility and treatment.” Pet. App. D2-D3.
The court also rejected Texas’ characterization of its
IRO program as a law that merely implements a minimal
level of care, like the state law at issue in Metropolitan
Life Ins. Co., 471 U.S. at 731, 758, by imposing a man-
datory insurance contract term. The court concluded in-
stead that “the [RO provisions here are plainly a state
regime for reviewing benefit decisions.” Pet. App. D6.
ARGUMENT
Texas contends that certiorari is warranted to re-
solve two distinct questions. First, Texas contends that
this Court should decide whether a state law that con-
flicts with the exclusive remedies set forth in ERISA
§ 502(a), 29 U.S.C. § 1132(a), can nonetheless avoid
federal preemption if that law regulates “insurance”
:
§
|
;
4
7
within the meaning of ERISA’s “saving clause,” 29
U.S.C. § 1144(b)(2)(A). Second, Texas argues that this
Court should consider whether state laws that provide
for external review of an MCO’s determination that a
particular treatment is not “medically necessary” are
preempted by ERISA or FEHBA. There is no conflict
among the lower courts with respect to Texas’ proposed
first question, which in any event is not properly pre-
sented in this case. With respect to the second question
framed by Texas, the Fifth Circuit’s ERISA preemption
analysis could be viewed as inconsistent with the ap-
proach employed by the Seventh Circuit in a recent case,
but any conflict between those two decisions is not yet
ripe for this Court’s review. Accordingly, plenary re-
view is not warranted.
I. THIS CASE DOES NOT PROPERLY PRE-
SENT THE ISSUE WHETHER STATE
STATUTES THAT CONFLICT WITH THE
EXCLUSIVE REMEDIES SET FORTH IN
SECTION 502 ARE SAVED FROM PRE-
EMPTION BY ERISA’S' “SAVING
CLAUSE.”
1. Texas first presents the question whether Section
502(a) of ERISA, 29 U.S.C. § 1132(a), is “an exclusive
remedy prevision that preempts state insurance law
remedies” that purportedly fall within the insurance
“saving clause” of Section 514 of the statute, 29 U.S.C.
§ 1144. In Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41
(1987), however, this Court unanimously concluded that
the remedies set forth in Section 502(a) are indeed ex-
clusive. As tiie Court explained:
[T]he detailed provisions of § 502(a) set forth a
comprehensive civil enforcement scheme that repre-
sents a careful balancing of [policy choices.] The
policy choices reflected in the inclusion of certain
remedies and the exclusion of others under the
federal scheme would be completely undermined if
ERISA-plan participants and beneficiaries were free
8
to obtain remedies under state law that Congress re-
jected in ERISA.
Pilot Life, 481 U.S. at 54. This Court found additional
support for the exclusivity of Section 502(a)’s remedies
in the legislative history of ERISA, which demonstrated
that Congress modeled the preemptive force of Sec-
tion 502(a) on Section 301 of the Labor-Management
Relations Act of 1947 (“LMRA”). See Pilot Life, 481
U.S. at 55. As this Court noted, Congress well under-
stood that Section 301 of the LMRA preempts state stat-
utes “even when [they] purport[] to authorize a remedy
unavailable under the federal provision.” Pilot Life, 481
U.S. at 55. Indeed, “the entire comparison of ERISA’s
§ 502(a) to §301 of the LMRA[] would make little
sense if the remedies available to ERISA participants
and beneficiaries under § 502(a) could be supplemented
or supplanted by varying state laws.” Pilot Life, 481
USS. at 56.
In light of this Court’s analysis in Pilot Life, any
state law that purports to “supplement[] or supplant[]”
the exclusive remedies that Congress made available in
Section 502(a) is invalid under conventional conflict
preemption principles. See, e.g., Boggs v. Boggs, 520
U.S. 833, 844 (1997) (“In the face of [a] direct clash be-
tween state law and the provisions and objectives of
ERISA, the state law cannot stand”). Texas submits,
however, that the Court’s analysis in Pilot Life does not
control when, as Texas contends is the case here, the
state law falls within the scope of ERISA’s saving
clause, 29 U.S.C.§ 1144(b)(2)(A). See Pet. 12-17. That
argument is at odds with the specific reasoning of Pilot
Life, which examined the effect of Section 502(a) in or-
der to inform the Court’s “understanding of the saving
clause,” Pilot Life, 481 U.S. at 52, and found Section
502(a)’s exclusive remedy to be an important factor in
4
|
;
.
.
5
.
9
determining that the state law was not saved under
ERISA § 514(b)(2)(A), 29 U.S.C. § 1144(b)(2)(A). See
Pilot Life, 481 U.S. at 57.4 As the Eighth Circuit has
observed, “Pilot Life could not have stated with any
greater clarity that the remedies afforded under ERISA
are exclusive, and no state law purporting to supply ad-
ditional remedies will escape * * * preempti[on] * * * as
laws ‘which regulate insurance’ under § 1144(b)(2)(A).”
In re Life Ins. Co. of N. Am., 857 F.2d 1190, 1194 (8th
Cir. 1988).
2. Texas correctly notes that the Solicitor General,
whose reasoning was adopted by this Court in Pilot Life,
see Pilot Life, 481 U.S. at 52, retreated from his posi-
tion in UNUM Life Ins. Co. of Am. v. Ward, 526 U.S.
358 (1999), and now apparently believes that ERISA’s
Saving clause may save from preemption even statutes
that conflict with the exclusive remedies provided by
Section 502 of ERISA. See UNUM, 526 U.S. at 376-77
n.7. At the outset, that contention overlooks key aspects
of this Court’s analysis in Pilot Life. Pilot Life did not
merely hold that Section 502 remedies are exclusive,
and thus preemptive of conflicting state laws under con-
ventional conflict preemption principles. Pilot Life also
held that the exclusivity of Section 502 remedies is so
important to ERISA’s design that it must inform judicial
interpretation of the scope of the business of “insurance”
that Congress intended to reserve for the States. That
Statutory term, the Court held, must be defined not only
4 Indeed, in Pilot Life this Court noted that its “understand-
ing of the saving clause must be informed by the legislative
intent concerning the civil enforcement provisions provided
by ERISA § 502(a),” and it found that Section 502(a)’s ex-
clusive remedial scheme was the “most important[{]” factor
indicating that the state law was not saved. See Pilot Life,
481 U.S. at 52, 57. Texas’ arguments here would turn that
analysis on its head.
10
on the basis of the McCarran-Ferguson guideposts, but
also with reference to “the role of the saving clause in
ERISA as a whole.” Pilot Life, 481 U.S. at 52. Thus,
Texas errs at the outset in presuming that Congress in-
tended to save for the States the authority to regulate
anything that might be viewed as “insurance” under a
common sense application of two out of the three
McCarran-Ferguson guideposts.
In any event, by accepting the Solicitor General’s
arguments, Pilot Life did not purport to give the Solici-
tor General a continuing proxy to change the rule of law
that this Court unanimously adopted in that case—a rule
that for nearly fifteen years has been part of the accepted
understanding of ERISA shared by litigants and the
lower courts. Indeed, far more than the Solicitor Gen-
eral’s change of heart would be necessary to meet the
high burden that must be “borne by the party advocating
the abandonment of an established precedent,” espe-
cially where, as here, “the Court is asked to overrule a
point of statutory construction.” Patterson v. McLean
Credit Union, 491 U.S. 164, 172 (1989).
Moreover, contrary to Texas’ assertions, there is no
conflict among the courts of appeals on the question
whether ERISA’s saving clause preserves from preemp-
tion state statutes that conflict with ERISA’s substantive
provisions. Although Texas suggests that the Seventh
Circuit’s recent decision in Moran v. Rush Prudential
HMO, Inc., 230 F.3d 959 (7th Cir. 2000), adopted such a
view, see Pet: 6-12, the Seventh Circuit did not remotely
suggest that it was departing from Pilot Life’s unani-
mous teaching that Section 502 is an exclusive provision
that preempts State laws that provide alternative or addi-
tional remedies to plan participants or beneficiaries.
Moran concluded that an Illinois statute that provides
for a form of external review could not properly be
characterized as an alternative or supplemental enforce-
ment mechanism precluded by Section 502(a), but rather
was a permissible “mandated contract term” that became
eS ee a ae ee
1]
part of ERISA plans—and thus is enforceable in an ac-
tion under Section 502(a)—by operation of state law.
Because the Seventh Circuit did not view the Illinois
statute as an impermissible state mechanism for enforc-
ing plan benefits, it found that the statute did not run
afoul of Section 502’s exclusive sweep. Moran, 230
F.3d at 970-72. That is far from holding that, were the
statute properly characterized as an alternative or sup-
plemental enforcement mechanism, it could nonetheless
be saved from preemption by the saving clause.5
Texas is even wider of the mark in claiming that
Williams Ins. Trust v. Travelers Ins. Co., 50 F.3d 144
(2d Cir. 1995), and PAS v. Travelers Ins. Co., 7 F.3d
349 (3d Cir. 1993), show that “[t]he Second and Third
Circuits do not view Pilot Life as an obstacle to saving
state insurance law remedies from preemption or to en-
forcement of those remedies in a state proceeding.” Pet.
15. In both Williams Trust and PAS the sole, narrow is-
sue properly before the court of appeals was whether the
state statutes at issue were so completely preempted by
ERISA that the defendants were entitled to remove ac-
tions filed under those statutes to federal court. Wil-
liams Trust, 50 F.3d at 146; PAS, 7 F.3d at 351. As
Texas doubtless is aware, this Court unanimously
ruled—on the same day it decided Pilot Life—that any
state cause of action that falls within the scope of the
civil enforcement provisions of Section 502(a) is so in-
herently and completely preempted that such a cause of
> Moran might be read as creating a conflict with the deci-
sion below only with respect to one half of the second ques-
tion that Texas has framed—i.e., whether ERISA (but not
FEHBA) preempts state laws that provide external review of
a managed care organization’s decision not to cover a par-
ticular treatment on the ground that such treatment is not
“medically necessary.” As discussed more fully below, any
such conflict is not ripe for review.
12
action may be removed to federal court. See Metropoli-
tan Life Ins. v. Taylor, 481 U.S. 58, 66 (1987). The
Court was careful to point out, however, that not all pre-
emption defenses support removal jurisdiction, and the
fact that a particular preemption claim does not support
“complete preemption” removal means only that the
preemption defense must be adjudicated by the state
courts—it does not mean that the statute is not pre-
empted. See id. at 63-64; see also Rivet v. Regions Bank
of Louisiana, 522 U.S. 470, 475-77 (1998); In re U.S.
Healthcare, Inc., 193 F.3d 151, 165 (3d Cir. 1999), cert.
denied, 120 S. Ct. 2687 (2000). The limited removal
rulings in Williams Trust and PAS could not properly
establish otherwise.
In any event, it is difficult to see how either Wil-
liams Ins. Trust or PAS can be read to support Texas’
claim that ERISA’s saving clause trumps all preemption
defenses under the statute. In Williams Ins. Trust the
case had been removed on the basis of ERISA’s general
preemption provision, 29 U.S.C. § 1144(a)}—the very
provision where the saving clause appears—and thus
conflict preemption was not even at issue in the case.
See Williams Trust, 50 F.3d at 147. PAS concluded that
ERISA did not completely preempt a state insurance law
that prohibited discrimination in the provision of mental
health benefits, reasoning that such a law did not con-
flict with the provisions of Section 502(a). PAS, 7 F.3d
at 356. Neither case can plausibly be read for the propo-
sition that state statutes that do conflict with Section
502(a) are immune from preemption if they satisfy
Texas’ proposed interpretation of the saving clause.
3. Even if this Court were otherwise inclined to en-
tertain the argument that Pilot Life should be revisited as
Texas desires, this case would not be the proper vehicle
in which to do so for three reasons. First, as explained
more fully below, while the court of appeals correctly
concluded that the saving clause does not save Texas’
external review requirements, that court was mistaken in
eee
EEE
13
believing that a common sense assessment of the
McCarran-Ferguson factors points to the conclusion that
Texas’ statute regulates insurance. For that reason, an
essential predicate for the question posed by Texas is
simply missing in this case.
Second, although Texas has always maintained that
its external review statute is not preempted by ERISA, it
did not argue below that a statute that conflicts with the
exclusive remedies provided by Section 502(a) may be
saved nonetheless if the statute meets Texas’ interpreta-
tion of ERISA’s saving clause. Texas’ argument has
been—and remains, see Pet. 11, 13—that there is no
conflict at all between Texas’ external review statute
and Section 502(a). Indeed, Texas advanced its saving-
clause argument below solely in an attempt to establish
that the external review provisions are not independently
preempted by ERISA § 514(a) as laws “relat[ing] to”
employee benefit plans, 29 U.S.C. § 1144(a). Texas did
not urge below the legal issue on which it now seeks re-
view: that the saving clause—interpreted solely by ref-
erence to the McCarran-Ferguson factors—is the begin-
ning and end of the analysis for all preemption defenses
under ERISA.® Not surprisingly, the court of appeals
did not consider any such claim. Thus, review of that
question would not be appropriate in this case solely be-
cause the court of appeals did apply ordinary principles
of conflict preemption. See, e.g., United States v. Wil-
liams, 504 U.S. 36, 41 (1992) (“Our traditional rule * *
* precludes a grant of certiorari * * * when the question
© Such an argument would have required Texas to request
that the court of appeals revisit en banc its analysis in Rami-
rez v. Intercontinental Hotels, 890 F.2d 760, 763-64 (Sth Cir.
1989). Neither Texas’ briefs before the panel nor its subse-
quent petition for rehearing en banc contained any such en-
treaty.
14
presented was not pressed or passed upon below’) (in-
ternal quotation marks omitted).
Finally, although SB 386 by its terms expressly
links the external review and liability provisions—thus
strongly suggesting the existence of a state-law cause of
action for members dissatisfied with the external review
process—the court of appeals construed the liability
provisions as extending only to “a limited universe of
events”—i.e., events that constitute medical negligence
by a treating physician, for which the MCO would be
vicariously liable. Pet. App. A8. In light of that con-
struction, Texas now asserts that its external review pro-
visions should be viewed as “creati[ing] a procedural
right that an ERISA beneficiary can assert in a § 502(a)
enforcement action.” Pet. 11; see also id. at 13 (external
review provisions are “incorporated into ERISA plans
and supply the relevant rule of decision in a § 502(a)
> suit”). Aetna disagrees that Texas’ external review re-
quirements are a mere procedural mechanism or that
state law may require “incorporation” of that mechanism
into the terms of ERISA plans. Nonetheless, as Texas
characterizes its own statute, this case does not present
the distinct legal question whether the saving clause
should be read to save state laws that conflict with Sec-
tion 502(a). See UNUM, 526 U.S. at 377 n.7 (“We need
not address the Solicitor General’s current argument, for
Ward has sued under § 502(a)(1)(B) for benefits due,
and seeks only application of saved state insurance law
as a relevant rule of decision in his § 502(a) action”).
Il. TEXAS’ STATUTE IS ~ CLEARLY
PREEMPTED BY ERISA BECAUSE IT
CONFLICTS WITH SECTION 502 AND IS
NOT SAVED FROM SECTION 514
PREEMPTION.
Texas’ independent review requirements purport to
establish a binding alternate enforcement mechanism for
claimants to receive plan benefits. That not only is pre-
cisely the sort of state law remedy that Congress in-
15
tended to preempt with ERISA’s comprehensive reme-
dial scheme in Section 502(a), but also runs afoul of
) ERISA’s express preemption provision, 29 U.S.C.
§ 1144.
1. ERISA’s express preemption provision provides
that ERISA “shall supersede any and all State laws inso-
far as they * * * relate to any employee benefit plan.”
ERISA § 514(a), 29 U.S.C. § 1144(a). Thus, any state
law that “relates to” an ERISA plan must give way to
7 ERISA’s preemptive reach. This Court has “long ac-
3 knowledged that ERISA’s pre-emption provision is
‘clearly expansive.’” California Div. of Labor Stand-
ards Enforcement v. Dillingham Constr., N.A., 519 U.S.
316, 324 (1997) (quoting New York State Conference of
| Blue Cross & Blue Shield Plans v. Travelers Ins. Co.,
| 514 U.S. 645, 656 (1995)). As this Court reaffirmed in
Travelers, “§ 514 indicates Congress’s intent to estab-
lish the regulation of employee welfare benefit plans ‘as
exclusively a federal concern.’” 7; ravelers, 514 U.S. at
656 (citation omitted); see also Alessi v Raybestos-
Manhattan, Inc., 451 U.S. 504, 523 (1981) (“[Section
514] demonstrates that Congress intended to * * * estab-
' lish pension plan regulation as exclusively a federal
' concern.”). To that end, Section 514(a) preempts any
state law that has a “connection with” or “reference to”
such a plan. Dillingham, 519 U.S. at 324 (citation omit-
ted).
The court of appeals in this case and the Seventh
Circuit in Moran—the only courts of appeals that have
considered whether ERISA preempts the type of statute
at issue here—both correctly concluded that external re-
view statutes plainly “relate to” ERISA plans under Sec-
tion 514(a). Pet. App. Al2-A13; Moran, 230 F.3d at
968-69. After all, a determination that a particular
treatment is not “medically necessary” does not prohibit
a member from receiving such a treatment; it is simply a
judgment that the plan under which the member iS COV-
ered is not obligated to pay for it—it is, in other words, a
16
coverage determination. See, e.g., Thompson v. Gen-
care Health Systems, Inc., 202 F.3d 1072, 1074 (8th Cir.
2000). By forcing ERISA plans to pay for treatments
that, in the plan’s view, are not covered, Texas’ external
review provisions would have the clearly impermissible
effect of “mandat[ing] employee benefit structures or
their administration” and of “binding plan administrators
to a[] particular choice.” Travelers, 514 U.S. at 658,
659; see also Shaw v. Delta Air Lines, Inc., 463 U.S. 85,
97 (1983). Indeed, because external review laws fun-
damentally interfere with the allocation and payment of
plan benefits to participants and beneficiaries in accor-
dance with the terms of the applicable plan documents,
those laws go to the very core of ERISA. See ERISA
§ 2(b), 29 U.S.C. § 1001(b) (“[It is] the policy of this
Act to protect * * * the interests of * * * beneficiaries”
in ERISA plans); Fort Halifax Packing Co. v. Coyne,
482 U.S. 1, 9 (1987) (explaining that ERISA plans are
“obligat[ed] . . . [to] determin[e] the eligibility of claim-
ants”’).
In addition, Texas’ independent review law, if per-
mitted to survive ERISA preemption, would frustrate
Congress’s aim of “‘avoid[ing] a multiplicity of regula-
tion in order to permit the nationally uniform
administration of employee benefit plans.’” Travelers,
514 U.S. at 657. As this Court explained in Fort Hali-
Jax: ‘An employer that makes a commitment systemati-
cally to pay certain benefits undertakes a host of ob-
ligations, such as determining the eligibility of
claimants * * * [and] making disbursements * * *
The most efficient way to meet these responsibilities
is to establish a uniform administrative scheme,
which provides a set of standard procedures to guide
processing of claims and disbursement of benefits.
Such a system is difficult to achieve, however, if a
benefit plan is subject to differing regulatory re-
quirements in differing States. A plan would be re-
is.
17
quired to * * *. process claims in a certain way in
some States but not in others * * *.,
Fort Halifax, 482 U.S. at 9. Here, as in Shaw, Holliday,
and Alessi, validation of Texas’ external review law
would impose inconsistent state requirements on the
administration of ERISA plans and thereby frustrate
ERISA’s clear purpose to “secur[e] national uniformity
: in the administration of employee benefit plans.” Boggs,
520 U.S. at 842.
Petitioners nonetheless contend that Pegram v. Her-
drich, 120 S. Ct. 2143 (2000), stands for the proposition
that the independent review provisions at issue here do
not “relate to” an ERISA plan, because Pegram noted
that coverage or “eligibility decisions cannot be untan-
gled from physicians’ judgments about reasonable
medical treatment.’” Pet. 24, quoting Pegram, 120 S.
Ct. at 2157. Pegram held that ERISA does not impose a
fiduciary duty on HMO physicians for their mixed eligi-
bility and treatment decisions, Pegram, 120 S. Ct. at
2158. Because Pegram was not a preemption case, this
Court “ha[d] no occasion to discuss” the standards gov-
erning a § 502(a) claim for benefits nor “the interaction
of such a claim with state law causes of action,” Pe-
gram, 120 S. Ct. at 2154 n.9; see also id. at 2158. In-
deed, to the extent that Pegram even so much as hinted
at any principle of preemption law, it at most suggested
that a physician who makes coverage decisions in the
course of treating his patients is not thereby shielded
from the state’s malpractice laws. That principle is un-
exceptionable but, as the court of appeals correctly noted
in denying Texas’ petition for rehearing, it is not par-
ticularly helpful to Texas here. Pet. App. D2-D3, n.7
(noting that even assuming that malpractice causes of
——_——__.—~ ~
18
action are not preempted, SB 386’s external review pro-
cedures “would still be preempted.”).’
2. The court of appeals correctly concluded that
ERISA’s saving clause does not save the external review
provisions of SB 386 from preemption. Pet. App. A15S.
The conflict between the external review provisions and
Section 502(a) alone establishes that those provisions
are not part of the business of “insurance” that Congress
intended to save from preemption. Pilot Life, 481 U.S.
at 52. But even if the inquiry were restricted to the
McCarran-Ferguson factors and “a common-sense view
of the matter” (UNUM, 526 U.S. at 367), the external
review provisions do not regulate insurance within the
meaning of the saving clause.®
7 Moreover, Pegram addressed mixed eligibility and treat-
ment decisions in the context of a “staff model” managed
care plan, in which physicians are employees of the plan and
make coverage decisions on behalf of the plan. Aetna does
not operate any “staff model” plans in Texas; as the court of
appeals noted, Aetna contracts with independent providers
and hospitals. Pet. App. A3. Indeed, under Texas law “staff
model” plans would likely run afoul of the State’s prohibition
on the corporate practice of medicine. See Garcia v. Texas
State Bd. of Med. Examiners, 384 F. Supp. 434, 437 (W.D.
Tex. 1974) (per curiam), aff'd, 421 U.S. 995 (1975). Thus, it
is hard to see how Pegram’s discussion of physicians who
make both medical and coverage judgments could have any
application to Aetna, which deals solely with coverage is-
sues.
8 The McCarran-Ferguson factors are “first, whether the
practice has the effect of transferring or spreading a policy-
holder’s risk; second, whether the practice is an integral part
of the policy relationship between the insurer and the in-
sured; and third, whether the practice is limited to entities
within the insurance industry.” UNUM, 526 US. at 367; see
also Metropolitan Life, 471 U.S. at 743. Although a law
[Footnote continued on next page]
19
Texas’ external review provisions do not “regulate
insurance” under a common sense understanding, be-
cause Texas’ law is not directed specifically at the man-
aged care industry as insurers or even at the insurance
industry in general. See UNUM, 526 '!.S. 375; Pilot
Life, 481 U.S. at 50. Rather, the IRO procedures pro-
vide a dispute resolution mechanism of certain coverage
determinations (those involving “medical necessity”), a
matter not unique to the insurance industry. To cite only
the most obvious example, Texas’ law expressly targets
not merely entities that assume risk for health care ser-
vices, but also “any other person or entity which * * *
administers * * * health benefits * * * pursuant to a pol-
icy, plan, or contract.” TEx. INS. CODE ANN. art.
21.58A §§ 2(17)(B) and (C), 2(21)(B), 6 and 6A.
Senate Bill 386 thus quite Clearly reaches not only
plans in which Aetna assumes some financial risks of
coverage, but also plans—particularly self-funded em-
ployee benefit plans—that Aetna merely administers in
exchange for a fee. Texas’ law expressly reaches, in
other words, the prime example of what Congress in-
tended for States not to reach under the guise of “insur-
ance.” See FMC Corp. v. Holliday, 498 U.S. 52, 61
(1990) (discussing ERISA’s “deemer clause,” 29 U.S.C.
§ 1144(b)(2)(B), which precludes states from using the
Saving clause to “deem” employee benefit plans “insur-
ers” or to “deem” such plans “to be engaged in the busi-
ness of insurance”). For that same reason, SB 386’s ex-
ternal review procedures do not satisfy the third McCar-
ran-Ferguson factor. Indeed, while the court of appeals
dismissed the third McCarran-F erguson factor on the
[Footnote continued from previous page]
need not meet all of three McCarran-F erguson factors to fall
within the protection of the Saving clause, see UNUM, 526
U.S. at 373, the Court has continued to scrutinize all three
factors.
20
theory that Texas may permissibly reach any “entities
acting as insurers,” Pet. App. Al4 (emphasis in origi-
nal), that is simply another way of saying that Texas
could permissibly “deem” self-funded plans to be “in-
surers” for regulatory purposes, a boundless theory that
would essentially nullify ERISA’s “deemer clause.” See
FMC Corp., 498 U.S. at 63-64.
Moreover, as the court of appeals essentially con-
ceded, Texas’ external review requirements do not meet
the first McCarran-Ferguson factor because they do not
operate to transfer or spread a policyholder’s nsk. See
Pet. App. A15 (“the provisions probably do not meet the
first factor”). Regardless of the particular remedy avail-
able to obtain benefits under the terms of a plan—
whether under Section 502(a) or through a state man-
dated appeals process of independent review—the basic
contract terms providing benefits to a policyholder for
“medically necessary” health care remain controlling.
See Union Labor Life Ins. Co. v. Pireno, 458 U.S. 119,
130-31 (1982). The relevant risk is fixed when the con-
tract is completed (id. at 131), and—notwithstanding
Texas’ law—a member’s health plan continues to bear
the risk of covering only “medically necessary” health
care, while members continue to bear the financial risk
of covering any desired health care that is not medically
necessary.
Finally, given Texas’ current insistence that its ex-
ternal review provisions merely mandate a “procedural
night” (Pet. 11), those provisions can scarcely be con-
sidered “integral” to any insurance relationship. Like
the state common law bad faith claim at issue in Pilot
Life, Texas’ IRO process “does not define the terms of
the relationship between the insurer and the insured; it
declares only that, whatever terms have been agreed
upon in the insurance contract, [such as, in this case,
coverage for “medically necessary” health care,] a
breach of that contract may * * * allow a policyholder to
21
obtain” certain state law remedies. Pilot Life, 481 U.S.
at 51.
In sum, because Texas’ IRO provisions fail to
“regulate insurance” from a common-sense view of the
matter and clearly fail to satisfy any of the McCarran-
~ Ferguson factors, those provisions cannot be viewed as
“regulating insurance” within the meaning of Sec-
tion 514(b)(2)(A). Accordingly, those provisions are
independently preempted not only under Section 502(a),
but also under Section 514(a).
3. In Moran, the Seventh Circuit recently held that
ERISA does not preempt an Illinois statute’s provisions
requiring independent review of certain medical neces-
sity decisions. Moran, 230 F.3d at 972-73. After con-
cluding that the Illinois law falls “squarely” within
ERISA’s express preemption clause because it would
affect benefit determination procedures (id. at 968), the
court concluded that Section 514 does not invalidate I]-
linois’ law because that law regulates insurance within
the meaning of the saving clause, id. at 969-70. With
respect to “conflict” preemption, the court determined
that the Illinois statute’s independent review provisions
do not “creat[e] an alternative remedy scheme that con-
flicts with [§] 502(a),” but rather are incorporated into
the terms of the insurance contract by operation of state
law. Id. at 970. Thus, the court held, any suit to enforce
the Illinois review procedures would be “simply a suit to
enforce the terms of the plan—precisely the sort of suit
that is contemplated by [§] 502(a)(1)(B).” Jd.9
9 Moran’s state law analysis appears to be based upon an
overly broad proposition of law that does not necessarily ap-
ply in this case. That proposition is that “Illinois laws auto-
matically are incorporated into all contracts of insurance in
that state.” Moran, 230 F.3d at 966; see also id. at 969. In
Texas, however, not every law is incorporated into every
[Footnote continued on next page]
22
As Judge Posner recognized in dissenting from the
Seventh Circuit’s denial of rehearing en banc, the
Moran panel’s logic would permit the “transparent * * *
evasion of ERISA’s preemption clause,” a result that is
plainly impermissible. Moran, 230 F.3d at 972-73 (Pos-
ner, J., dissenting from denial of rehearing en banc).
States could evade ERISA through the simple artifice of
declaring that a state law that ERISA would otherwise
preempt is “incorporated” into the terms of a plan. That
anomalous analysis may merit this Court’s review in an
appropriate case, but review at this time would be pre-
mature. Only two courts of appeals have even consid-
ered whether ERISA preempts state laws that require
external review, even though, according to Texas and its
amici, “[m]Jany states” have adopted “some form of in-
dependent, external review process.” Pet. 27 & n.24;
see also Brief of the States of Massachusetts ef al. as
Amici Curiae in Support of Petitioners at 2 &. n.4.10
[Footnote continued from previous page]
contract of insurance. See Jun v. Lloyds, No. 03-00-00110-
CV, 2000 WL 1675683, at *3-4 (Tex. App.-Austin, Nov. 9,
2000, no pet. hist.).
10 Contrary to Texas’ petition for certiorari, there is no con-
flict among other courts of appeals about whether ERISA
preempts state independent review laws. See Pet. 13-15.
The decisions from Second, Third, Sixth and Eighth Circuits
on which Texas relies involved state insurance laws which,
unlike the state independent review law at issue here, do not
urport to establish additional remedies in conflict with
§ 502(a), but merely mandate minimum insurance benefits,
like the insurance law held not preempted in Metropolitan
Life Ins. Co. v. Massachusetts, 471 U.S. 724 (1985). See
Williams Ins. Trust, 50 F.3d at 151 (state insurance law re-
quiring that interest on life insurance benefits be computed
from the date of death); PAS, 7 F.3d at 356-57 (state insur-
ance law prohibiting discrimination in the provision of men-
[Footnote continued on next page]
23
The widespread adoption of such laws should afford this
Court ample opportunity to address the issues raised by
Texas after several other courts of appeals have had an
adequate opportunity to address the interrelation be-
tween external review laws and ERISA. Indeed, if
Texas is correct that Pegram has some relevance to the
preemption analysis that applies in this context—though
neither the Fifth Circuit nor the Seventh Circuit believed
that Pegram addressed the issues presented here—the
very recency of that decision would itself counsel
against review of Texas’ arguments at this time, before
the lower courts have had an adequate opportunity to
assimilate that ruling.
As this Court has recognized, the percolation of im-
portant legal questions throughout the judicial system
prior to a grant of a writ of certiorari offers this Court
the benefits of enhanced development and consideration
of the issues and of the various factual settings in which
they arise. See, e.g., United States v. Mendoza, 464 U.S.
154, 160 (1984); EZ. du Pont de Nemours & Co. v.
Train, 430 U.S. 112, 135 n.26 (1977) (noting the “wis-
dom of allowing difficult issues to mature through full
consideration by the courts of appeals”). That percola-
tion could obviate any need for review altogether—by
solidifying lower court support for the correct rule and
[Footnote continued from previous page]
tal health benefits); Ruble v. UNUM Life Insurance Co. of
Am., 913 F.2d 295, 297 (6th Cir. 1990) (state insurance law
prohibiting insurance benefits from being reduced by any
amount of social security benefits received); Donatelli v.
Home Insurance Co., 992 F.2d 763; 764-65 (8th Cir. 1993)
(state insurance law requiring insurers to provide accidental
death benefits in the event of death by suicide while insane).
Unlike the state IRO procedures at issue here, those cases did
not approve an alternate remedial scheme that directly con-
flicts with ERISA’s civil enforcement provisions.
24
causing the Seventh Circuit to reconsider Moran's rule
en banc.
Permitting further percolation of the preemption is-
sue in the lower courts is particularly appropriate be-
cause the apparent disagreement between the Seventh
and Fifth circuits may be rendered moot by federal legis-
lative or regulatory developments. Leaders of both po-
litical parties are currently advocating separate versions
of a Patients’ Bill of Rights. See, e.g., H.R. 2990, 106th
Cong. (1999); H.R. 2723, 106th Cong. (1999); S. 1344,
106th Cong. (1999); S.Amend. 3694, 106th Cong.
(2000); BNA’s Health Care Daily Report, Plan Regula-
tion: Bill of Rights Could Make Comeback in Next Ses-
sion; Business Groups Prepare, Bureau of National Af-
fairs, Inc. (Dec. 6, 2000). The Senate and House ver-
sions of that bill contain provisions for external inde-
pendent review at Sections 121 and 1103, respectively.
See, e.g., H.R. 2990, 106th Cong. (1999). That legisla-
tion might well achieve many of the objectives of meas-
ures such as SB 386, without disrupting the nationally
uniform regulation of employee benefit plans that Con-
gress intended in ERISA. Travelers, 514 U:S. at 656.
In addition, less than three weeks ago the U.S. De-
partment of Labor published a new ERISA regulation
that revises the benefit claims procedures for ERISA
plans. 65 Fed. Reg. 70246 (2000) (to be codified at 29
C.F.R. Part 2560). In particular, the regulation estab-
lishes new standards for the conduct of reviews of ad-
verse benefit determinations with respect to group health
plans and plans providing disability benefits. The regu-
lation requires de novo review of such determinations by
a third party fiduciary who is neither the individual who
made the initial determination nor that person’s subordi-
nate. Jd. at 70268-69 (to be codified at 29 C.F.R. Part
2560.503-—1(h)). In addition, the review must take into
account all comments, documents, records, and other
information submitted by the claimant, without regard to
whether such information was previously submitted or
25
relied upon in the initial determination. Jd. at 70269.
With regard to reviews of determinations based on a
medical judgment, including medical necessity and ap-
propriateness decisions, the regulation requires consulta-
tion with an appropriately qualified health care profes-
sional who is different from, and not subordinate to, any
individual who was consulted in connection with the ini-
tial decision. Jd. The effect of that new regulation on
the issue of ERISA’s preemption of state external re-
view laws has yet to be evaluated by any lower federal
court. In these circumstances, review by this Court of
the decision below would be premature and unwar-
ranted.
Ill. TEXAS HAS FAILED TO IDENTIFY ANY
REASON WARRANTING REVIEW OF
THE FIFTH CIRCUIT’S FEHBA RULING.
The court of appeals determined that FEHBA pre-
empts SB 386’s independent review procedures because
those procedures squarely conflict with the administra-
tive benefit review procedures established by the Office
of Personnel Management under FEHBA. Pet. App.
Al7 (citing 5 U.S.C. § 8902(j); 5 C.F.R. § 890.105-
890.107). Although Texas’ second question ostensibly
seeks review of that determination (see Pet. i), Texas
presents no argument impugning the correctness of the
court of appeals’ FEHBA analysis and identifies no
lower court conflict of any sort on that issue. Indeed,
although the bulk of Texas’ arguments under ERISA de-
rive from Texas’ assertion that SB 386 is a permissible
regulation of insurance, FEHBA expressly preempts
state laws relating to “insurance.” See 5 U.S.C.
§ 8902(m)(1). Because Texas proffers no reason for this
Court to review any FEHBA issue, this Court should
consider Texas’ FEHBA claim abandoned.
26
CONCLUSION
The petition for a wnt of certiorari should be denied.
Respectfully submitted.
JOHN B. SHELY MIGUEL A. ESTRADA
KENDALL M. GRAY Counsel of Record
ANDREWS & KURTH LLP. RACHEL A. CLARK
600 Travis, Suite 4200 GIBSON, DUNN & CRUTCHER LLP
Houston, Texas 77002 1050 Connecticut Avenue, N.W.
(713) 220-4200 Washington, D.C. 20036
(202) 955-8500
Counsel for Respondents
December 8, 2000
APPENDIX
la
CONSTITUTIONAL AND STATUTORY
APPENDIX
CONSTITUTION OF THE UNITED STATES OF
AMERICA
ARTICLE VI, CLAUSE 2
This Constitution, and the Laws of the United States
which shall be made in Pursuance thereof; and all Trea-
ties made, or which shall be made, under the Authority
of the United States, shall be the supreme Law of the
Land; and the Judges in every State shall be bound
thereby, any Thing in the Constitution or Laws of any
State to the Contrary notwithstanding.
TEXAS SENATE BILL 386
AN ACT
relating to review of and liability for certain health care
treatment decisions.
BE IT ENACTED BY THE LEGISLATURE OF
THE STATE OF TEXAS:
SECTION 1. Title 4, Civil Practice and Remedies
Code, is amended by adding Chapter 88 to read as fol-
lows:
CHAPTER 88. HEALTH CARE LIABILITY
Sec. 88.001. DEFINITIONS. In this chapter:
(1) “Appropriate and medically necessary” means
the standard for health care services as determined by
physicians and health care providers in accordance with
the prevailing practices and standards of the medical
profession and community.
(2) “Enrollee” means an individual who is enrolled
in a health care plan, including covered dependents.
2a
(3) “Health care plan” means any plan whereby any
person undertakes to provide, arrange for, pay for, or re-
imburse any part of the cost of any health care services.
(4) “Health care provider” means a person or entity
as defined in Section 1.03(a)(3), Medical Liability and
Insurance Improvement Act of Texas (Article 4590i,
Vernon’s Texas Civil Statutes).
(5) “Health care treatment decision” means a de-
termination made when medical services are actually
provided by the health care plan and a decision which
affects the quality of the diagnosis, care, or treatment
provided to the plan’s insureds or enrollees.
(6) “Health insurance carrier” means an authorized
insurance company that issues policies of accident and
sickness insurance under Section 1, Chapter 397, Acts of
the 54th Legislature, 1955 (Article 3.70-1, Vernon’s
Texas Insurance Code).
(7) “Health maintenance organization” means an
organization licensed under the Texas Health Mainte-
‘nance Organization Act (Chapter 20A, Vernon’s Texas
Insurance Code).
(8) “Managed care entity’‘ means any entity which
delivers, administers, or assumes risk for health care
services with systems or techniques to control or influ-
ence the quality, accessibility, utilization, or costs and
prices of such services to a defined enrollee population,
but does not include an employer purchasing coverage
or acting on behalf of its employees or the employees of
one or more subsidiaries or affiliated corporations of the
employer or a pharmacy licensed by the State Board of
Pharmacy.
(9) “Physician” means:
(A) an individual licensed to practice medicine
in this state;
3a
(B) a professional association organized under
the Texas Professional Association Act (Article
1528f, Vernon’s Texas Civil Statutes) or a nonprofit
health corporation certified under Section 5.01,
Medical Practice Act (Article 4495b, Vernon’s
Texas Civil Statutes); or
(C) another person wholly owned by physicians.
(10) “Ordinary care” means, in the case of a
health insurance carrier, health maintenance organiza-
tion, or managed care entity, that degree of care that a
health insurance carrier, health maintenance organiza-
tion, or managed care entity of ordinary prudence would
use under the same or similar circumstances. In the case
of a person who is an employee, agent, ostensible agent,
or representative of a health insurance carrier, health
maintenance organization, or managed care entity, “or-
dinary care” means that degree of care that a person of
ordinary prudence in the same profession, specialty, or
area of practice as such person would use in the same or
similar circumstances.
Sec. 88.002. APPLICATION. (a) A health insur-
ance carrier, health maintenance organization, or other
managed care entity for a health care plan has the duty
to exercise ordinary care when making health care treat-
ment decisions and is liable for damages for harm to an
insured or enrollee proximately caused by its failure to
exercise such ordinary care.
(b) A health insurance carrier, health maintenance
organization, or other managed care entity for a health
care plan is also liable for damages for harm to an in-
sured or enrollee proximately caused by the health care
treatment decisions made by its:
(1) employees;
(2) agents;
(3) ostensible agents; or
4a
(4) representatives who are acting on its behalf
and over whom it has the right to exercise influence
or control or has actually exercised influence or con-
trol which result in the failure to exercise ordinary
care.
(c) It shall be a defense to any action asserted
against a health insurance carrier, health maintenance
organization, or other managed care entity for a health
care plan that:
(1) neither the health insurance carrier, health
maintenance organization, or other managed care
entity, nor any employee, agent, ostensible agent, or
representative for whose conduct such health insur-
ance carmer, health maintenance organization, or
other managed care entity is liable under Subsection
(b), controlled, influenced, or participated in the
health care treatment decision; and
(2) the health insurance carrier, health mainte-
nance organization, or other managed care entity did
not deny or delay payment for any treatment pre-
scribed or recommended by a provider to the in-
sured or enrollee.
(d) The standards in Subsections (a) and (b) create
no obligation on the part of the health insurance carrier,
health maintenance organization, or other managed care
entity to provide to an insured or enrollee treatment
which is not covered by the health care plan of the en-
tity.
(e) This chapter does not create any liability on the
part of an employer, an employer group purchasing or-
ganization, or a pharmacy licensed by the State Board of
Pharmacy that purchases coverage or assumes nsk on
behalf of its employees.
(f) A health insurance carrer, health maintenance
organization, or managed care entity may not remove a
physician or health care provider from its plan or refuse
Sa
to renew the physician or health care provider with its
plan for advocating on behalf of an enrollee for appro-
priate and medically necessary health care for the enrol-
lee.
(g) A health insurance carrier, health maintenance
organization, or other managed care entity may not enter
into a contract with a physician, hospital, or other health
care provider or pharmaceutical company which in-
cludes an indemnification or hold harmless clause for
the acts or conduct of the health insurance carrier, health
maintenance organization, or other managed care entity.
Any such indemnification or hold harmless clause in an
existing contract is hereby declared void.
(h) Nothing in any law of this state prohibiting a
health insurance carrier, health maintenance organiza-
tion, or other managed care entity from practicing medi-
cine or being licensed to practice medicine may be as-
serted as a defense by such health insurance carrier,
health maintenance organization, or other managed care
entity in an action brought against it pursuant to this sec-
tion or any other law.
(i) In an action against a health insurance carrier,
health maintenance organization, or managed care en-
tity, a finding that a physician or other health care pro-
vider is an employee, agent, ostensible agent, or repre-
sentative of such health insurance carrier, health mainte-
nance organization, or managed care entity shall not be
based solely on proof that such person’s name appears in
a listing of approved physicians or health care providers
made available to insureds or enrollees under a health
care plan.
(j) This chapter does not apply to workers’
compensation insurance coverage as defined in Section
401.011, Labor Code.
(k) An enrollee who files an action under this chap-
ter shall comply with the requirements of Section 13.01,
Medical Liability and Insurance Improvement Act of
6a
Texas (Article 45901, Vernon’s Texas Civil Statutes), as
it relates to cost bonds, deposits, and expert reports.
Sec. 88.003. LIMITATIONS ON CAUSE OF
ACTION. (a) A person may not maintain a cause of ac-
tion under this chapter against a health insurance carrier,
health maintenance organization, or other managed care
entity that 1s required to comply with the utilization re-
view requirements of Article 21.58A, Insurance Code,
or the Texas Health Maintenance Organization Act
(Chapter 20A Vernon’s Texas Insurance Code), unless
the affected insured or enrollee or the insured’s or enrol-
lee’s representative:
(1) has exhausted the appeals and review appli-
cable under the utilization review requirements; or
(2) before instituting the action:
(A) gives written notice of the claim as
provided by Subsection (b); and
(B) agrees to submit the claim to a review
by an independent review organization under
Article 21.58A, Insurance Code, as required by
Subsection (c).
(b) The notice required by Subsection (a)(2)(A)
must be delivered or mailed to the health insurance car-
rier, health maintenance organization, or managed care
entity against whom the action is made not later than the
30th day before the date the claim is filed.
(c) The insured or enrollee or the insured’s or
enrollee’s representative must submit the claim to a re-
view by an independent review organization if the health
insurance carner, health maintenance organization, or
managed care entity against whom the claim is made re-
quests the review not later than the 14th day after the
date notice under Subsection (a)(2)(A) is received by the
health insurance carner, health maintenance organiza-
tion, or managed care entity. If the health insurance car-
ner, health maintenance organization, or managed care
7a
entity does not request the review within the period
specified by this subsection, the insured or enrollee or
the insured’s or enrollee’s representative is not required
to submit the claim to independent review before main-
taining the action.
(d) Subject to Subsection (e), if the enrollee has not
complied with Subsection (a), an action under this sec-
tion shall not be dismissed by the court, but the court
may, in its discretion, order the parties to submit to an
independent review or mediation or other nonbinding al-
ternative dispute resolution and may abate the action for
a penod of not to exceed 30 days for such purposes.
Such orders of the court shall be the sole remedy avail-
able to a party complaining of an enrollee’s failure to
comply with Subsection (a).
(e) The enrollee is not required to comply with
Subsection (c) and no abatement or other order pursuant
to Subsection (d) for failure to comply shall be imposed
if the enrollee has filed a pleading alleging in substance
that:
(1) harm to the enrollee has already occurred
because of the conduct of the health insurance car-
ner, health maintenance organization, or managed
care entity or because of an act or omission of an
employee, agent, ostensible agent, or representative
of such carner, organization, or entity for whose
conduct it is liable under Section 88.002(b); and
(2) the review would not be beneficial to the
enrollee, unless the court, upon motion by a defen-
dant carrier, organization, or entity finds after hear-
ing that such pleading was not made in good faith,
in which case the court may enter an order pursuant
to Subsection (d).
(f) If the insured or enrollee or the insured’s or en-
rollee’s representative seeks to exhaust the appeals and
review or provides notice, as required by Subsection (a),
before the statute of limitations applicable to a claim
8a
against a managed care entity has expired, the limita-
tions period is tolled until the later of:
(1) the 30th day after the date the insured or en-
rollee or the insured’s or enroillee’s representative
has exhausted the process for appeals and review
applicable under the utilization review requirements;
or
(2) the 40th day after the date the insured or en-
rollee or the insured’s or enrollee’s representative
gives notice under Subsection (a)(2)(A).
(g) This section does not prohibit an insured or en-
rollee from pursuing other appropriate remedies, includ-
ing injunctive relief, a declaratory judgment, or relief
available under law, if the requirement of exhausting the
process for appeal and review places the insured’s or en-
rollee’s health in serious jeopardy.
SECTION 2. Section 6, Article 21.58A, Insur-
ance Code, is amended by amending Subsection (b) and
adding Subsection (c) to read as follows:
(b) The procedures for appeals must be reasonable
and shall include the following:
(1) a provision that an enrollee, a person acting
on behalf of the enrollee, or the enrollee’s physician
or health care provider may appeal the adverse de-
termination and shall be provided, on request, a
clear and concise statement of the clinical basis for
the adverse determination;
(2) a list of documents needed to be submitted
by the appealing party to the utilization review agent
for the appeal;
(3) a provision that appeal decisions shall be
made by a physician, provided that, if the appeal is
denied and within 10 working days the health care
provider sets forth in writing good cause for having
a particular type of a specialty provider review the
9a
case, the denial shall be reviewed by a health care
provider in the same or similar specialty as typically
manages the medical condition, procedure, or treat-
ment under discussion for review of the adverse de-
termination;
(4) in addition to the written appeal, a method
for an expedited appeal procedure for emergency
care denials and denials of continued stays for hos-
pitalized patients, which shall include a health care
provider who has not previously reviewed the case;
such appeal must be completed no later than one
working day following the day on which the appeal,
including all information necessary to complete the
appeal, is made to the utilization review agent; and
(5) written notification to the appealing party of
the determination of the appeal, as soon as practical,
but in no case later than the 30th day after the date
the utilization agent receives [:
the appeal. If
the appeal is denied, the written notification shall
include a clear and concise statement of:
(A) the clinical basis for the appeal’s de-
nial;
(B) [and] the specialty of the physician
making the denial; and
(C) notice of the appealing party’s right to
seek review of the denial by an independent re-
view organization under Section 6A of this arti-
cle and the procedures for obtaining that review.
(c) Notwithstanding any other law, in a circum-
stance involving an enrollee’s life-threatening condition,
the enrollee is entitled to an immediate appeal to an in-
dependent review organization as provided by Section
6A of this article and is not required to comply with pro-
cedures for an internal review of the utilization review
agent’s adverse determination. For purposes of this sec-
10a
tion, “hfte-threatening condition” means a disease or
other medical condition with respect to which death is
probable unless the course of the disease or condition is
interrupted.
SECTION 3. Article 21.58A, Insurance Code, is
amended by adding Section 6A to read as follows:
Sec.6A. INDEPENDENT REVIEW OF AD-
VERSE DETERMINATIONS. A utilization review
agent shall:
(1) permit any party whose appeal of an ad-
verse determination is denied by the utilization re-
view agent to seek review of that determination by
an independent review organization assigned to the
appeal in accordance with Article 21.58C of this
code;
(2) provide to the appropriate independent re-
view organization not later than the third business
day after the date that the utilization review agent
receives a request for review a copy of:
(A) any medical records of the enrollee
that are relevant to the review;
(B) any documents used by the plan in
making the determination to be reviewed by the
organization;
(C) the written notification described by
Section 6(b)(5) of this article;
(D) any documentation and written infor-
mation submitted to the utilization review agent
in support of the appeal; and
(E) a list of each physician or health care
provider who has provided care to the enrollee
and who may have medical records relevant to
the appeal;
lla
(3) comply with the independent review or-
ganization’s determination with respect to the medi-
cal necessity or appropriateness of health care items
and services for an enrollee; and
(4) pay for the independent review.
SECTION 4. Section 8, Article 21.58A, Insur-
ance Code, is amended by adding Subsection (f) to read
as follows:
(f) Confidential information in the custody of a
utilization review agent may be provided to an inde-
pendent review organization, subject to rules and stan-
dards adopted by the commissioner under Article
21.58C of this code.
SECTION 5. Subdivision (3), Subsection (a),
Section 9, Texas Health Maintenance Organization Act
(Article 20A.09, Vernon’s Texas Insurance Code), is
amended to read as follows:
(3) An evidence of coverage shall contain:
(A) no provisions or statements which are
unjust, unfair, inequitable, misleading, decep-
tive, which encourage misrepresentation, or
which are untrue, misleading, or deceptive as
defined in Section 14 of this Act; and
(B) a clear and complete statement, if a
contract, or a reasonably complete facsimile, if a
certificate, of:
(i) the medical, health care
services, or single health care service
and the issuance of other benefits, if
any, to which the enrollee is entitled
under the health care plan or single
health care service plan;
(ii) any limitation on the ser-
vices, kinds of services, benefits, or
kinds of benefits to be provided, in-
12a
cluding any deductible or co-
payment feature;
(iii) where and in what manner
information is available as to how
services may be obtained; and
(iv) a clear and understandable
description of the health maintenance
organization’s methods for resolving
enrollee complaints, including the
enrollee’s nght to appeal denials of
an adverse determination, as that
term is defined by Section 12A of
this Act, to an independent review
organization and the procedures for
making an appeal to an independent
review organization. Any subse-
quent changes may be evidenced in a
separate document issued to the en-
rollee.
SECTION 6. Section 12, Texas Health Mainte-
nance Organization Act (Article 20A.12, Vernon’s
Texas Insurance Code), is amended to read as follows:
Sec. 12. COMPLAINT SYSTEM. (a) Every
health maintenance organization shall establish and
maintain a complaint system to provide reasonable pro-
cedures for the resolution of oral and written complaints
initiated by enrollees concerning health care services.
(b) The commissioner may examine the complaint
system.
SECTION 7. The Texas Health Maintenance Or-
ganization Act (Chapter 20A, Vernon’s Texas Insurance
Code) is amended by adding Section 12A to read as fol-
lows:
Sec. 12A. REVIEW OF # ADVERSE
DETERMINATIONS. (a) The complaint system re-
quired by Section 12 of this Act must include:
l3a
(1) notification to the enrollee of the enrollee’s
right to appeal an adverse determination to an inde-
pendent review organization;
(2) notification to the enrollee of the procedures
for appealing an adverse determination to an inde-
pendent review organization; and
(3) notification to an enrollee who has a life-
threatening condition of the enrollee’s nght to im-
mediate review by an independent review organiza-
tion and the procedures to obtain that review.
(b) The provisions of Article 21.58A, Insurance
Code, that relate to independent review apply to a health
maintenance organization under this section as if the
health maintenance organization were a utilization re-
view agent.
(c) In this section:
(1) “Adverse determination” means determina-
tion by a health maintenance organization that the
health care services furnished or proposed to be fur-
nished to an enrollee are not medically necessary.
(2) “Independent review organization” means
an organization selected as provided under Article
21.58C, Insurance Code.
(3) “Life-threatening condition” has the mean-
ing assigned by Section 6, Article 21.58A, Insurance
Code.
SECTION 8. Subchapter E, Chapter 21,
Insurance Code, is amended by adding Article
21.58C to read as follows:
Art. 21.58C. STANDARDS FOR INDEPENDENT
REVIEW ORGANIZATIONS
Sec. 1. Definitions. In this article:
(1) “Life-threatening condition” has the mean-
ing assigned by Section 6, Article 21.58A of this
code.
(2) “Payor” has the meaning assigned by Sec-
tion 2, Article 21.58A of this code.
Sec.2. CERTIFICATION AND DESIGNA-
TION OF INDEPENDENT REVIEW ORGANIZA-
TIONS. (a) The commissioner shall:
(1) promulgate standards and rules for:
(A) the certification, selection, and opera-
tion of independent review organizations to per-
form independent review described by Section
6, Article 21.58A of this code; and
(B) the suspension and revocation of the
certification;
(2) designate annually each organization that
meets the standards as an independent review or-
ganization;
(3) charge payors fees in accordance with this
article as necessary to fund the operations of inde-
pendent review organizations; and
(4) provide ongoing oversight of the independ-
ent review organizations to ensure continued com-
pliance with this article and the standards and rules
adopted under this article.
(b) The standards required by Subsection (a)(1) of
this section must ensure:
(1) the timely response of an independent re-
view organization selected under this article;
(2) the confidentiality of medical records
transmitted to an independent review organization
for use in independent reviews;
15a
(3) the qualifications and independence of each
health care provider or physician making review de-
terminations for an independent review organiza-
tion;
(4) the fairness of the procedures used by an in-
dependent review organization in making the deter-
minations; and
(5) timely notice to enrollees of the results of
the independent review, including the clinical basis
for the determination.
(c) The standards adopted under Subsection (a)(1)
of this section must include standards that require each
independent review organization to make its determina-
tion:
(1) not later than the earlier of:
(A) the 15th day after the date the inde-
pendent review organization receives the infor-
mation necessary to make the determination; or
(B) the 20th day after the date the inde-
pendent review organization receives the re-
quest that the determination be made; and
(2) in the case of a life-threatening condition,
not later than the earlier of:
(A) the fifth day after the date the inde-
pendent review organizetion receives the infor-
mation necessary to make the determination; or
(B) the eighth day after the date the inde-
pendent review organization receives the re-
quest that the determination be made.
(d) To be certified as an independent review or-
ganization under this article, an organization must sub-
mit to the commissioner an application in the form re-
quired by the commissioner. The application must in-
clude:
loa
(1) tor an applicant that is publicly held, the
name of each stockholder or owner of more than
five percent of any stock or options;
(2) the name of any holder of bonds or notes of
the applicant that exceed $100,000;
(3) the name and type of business of each cor-
porauion or other organization that the applicant con-
trols or 1s athihated with and the nature and extent of
the affiliation or control;
(4) the name and a biographical sketch of each
director, officer, and executive of the applicant and
any entity listed under Subdivision (3) of this sub-
section and a descnption of any relationship the
named individual has with:
(A) a health benefit plan;
(B) a health maintenance organization;
(C) an insurer;
(D) a utilization review agent;
(E) a nonprofit health corporation;
(F) a payor;
(G) a health care provider; or
(H) a group representing any of the entities
described by Paragraphs (A) through (G) of this
subdivision;
(5) the percentage of the applicant’s revenues
that are anticipated to be derived from reviews con-
ducted under Section 6A, Article 21.58A of this
code;
(6) a description of the areas of expertise of the
health care professionals making review determina-
tions tor the applicant; and
(7) the procedures to be used by the independ-
ent review organization in making review determi-
17a
nations with respect to reviews conducted under
Section 6A, Article 21.58A of this code.
(e) The independent review organization shall an-
nually submit the information required by Subsection (d)
of this section. If at any time there is a material change
in the information included in the application under
Subsection (d) of this section, the independent review
organization shall submit updated information to the
commissioner.
(f) An independent review organizatron may not be
a subsidiary of, or in any way owned or controlled by, a
payor or a trade or professional association of payors.
(g) An independent review organization conducting
a review under Section 6A, Article 21.58A of this code
is not liable for damages arising from the determination
made by the organization. This subsection does not ap-
ply to an act or omission of the independent review or-
ganization that is made in bad faith or that involves
gross negligence.
SECTION 9. Chapter 88, Civil Practice and
Remedies Code, as added by this Act, applies only to a
cause of action that accrues on or after the effective date
of this Act. An action that accrues before the effective
date of this Act is governed by the law applicable to the
action immediately before the effective date of this Act,
and that law is continued in effect for that purpose.
SECTION 10. (a) The change in law made by
Sections 2 through 4 and 6 through 8 of this Act applies
only to an adverse determination of a utilization review
agent or health maintenance organization made on or af-
ter the effective date of this Act.
(b) The change in law made by Section 5 of this
Act to Section 9, Texas Health Maintenance Organiza-
tion Act (Article 20A.09, Vernon’s Texas Insurance
Code), applies only to an evidence of coverage that is
delivered, issued for delivery, or renewed on or after
18a
January 1, 1998. An evidence of coverage that is deliv-
ered, issued for delivery, or renewed before January 1,
1998, is governed by the law as it existed immediately
before the effective date of this Act, and that law is con-
tinued in effect for that purpose.
SECTION 11. This Act takes effect September 1,
1997.
SECTION 12. The importance of this legislation
and the crowded condition of the calendars in both
houses create an emergency and an imperative public
necessity that the constitutional rule requiring bills to be
read on three several days in each house be suspended,
and this rule is hereby suspended.
TITLE 29—LABOR
CHAPTER 18—EMPLOYEE RETIREMENT
INCOME SECURITY PROGRAM
SUBCHAPTER I—PROTECTION OF EMPLOYEE
BENEFIT RIGHTS
SUBTITLE A—GENERAL PROVISIONS
* * * * *
Part 5—Administration and Enforcement
* * * * *
§ 1132. Civil enforcement
(a) Persons empowered to bring a civii action
A civil action may be brought—
(1) by a participant or beneficiary—
(A) for the relief provided for in subsec-
tion (c) of this section, or
(B) to recover benefits due to him under
the terms of his plan, to enforce his nghts under
19a
the terms of the plan, or to clarify his nghts to
future benefits under the terms of the plan;
(2) by the Secretary, or by a participant, benefi-
ciary or fiduciary for appropriate relief under section
1109 of this title;
(3) by a participant, beneficiary, or fiduciary
(A) to enjoin any act or practice which violates any
provision of this subchapter or the terms of the plan,
or (B) to obtain other appropriate equitable relief (1)
to redress such violations or (11) to enforce any pro-
visions of this subchapter or the terms of the plan;
(4) by the Secretary, or by a participant, or
beneficiary for appropriate relief in the case of a
violation of 105(c) of this title;
(5) except as otherwise provided in subsection
(b) of this section, by the Secretary (A) to enjoin any
act or practice which violates any provision of this
subchapter, or (B) to obtain other appropriate equi-
table relief (i) to redress such violation or (ii) to en-
force any provision of this subchapter;
(6) by the Secretary to collect any civil penalty
under paragraph (2), (4), (5), or (6) of subsection (c)
or under subsection (1) or (/) of this section;
(7) by a State to enforce compliance with a
qualified medical child support order (as defined in
section 1169(a)(2)(A) of this title;
(8) by the Secretary, or by an employer or other
person referred to in section 1021(f)(1) of this title,
(A) to enjoin any act or practice which violates sub-
section (f) of section 1021 of this title, or (B) to ob-
tain appropriate equitable relief (1) to redress such
violation or (11) to enforce such subsection; or
(9) in the event that the purchase of an insur-
ance contract or insurance annuity in connection
with termination of an individual’s status as a par-
20a
ticipant covered under a pension plan with respect to
all or any portion of the participant’s pension benefit
under such plan constitutes a violation of part 4 of
this title [subtitle] or the terms of the plan, by the
Secretary, by any individual who was a participant
or beneficiary at the time of the alleged violation, or
by a fiduciary, to obtain appropriate relief, including
the posting of security if necessary, to assure receipt
by the participant or beneficiary of the amounts pro-
vided or to be provided by such insurance contract
or annuity, plus reasonable prejudgment interest on
such amounts.
z * * * *
§ 1144. Other laws
(a) Supersedure; effective date
Except as provided in subsection (b) of this section,
the provisions of this subchapter and subchapter III of
this chapter shall supersede any and all State laws inso-
far as they may now or hereafter relate to any employee
benefit plan described in section 1003(a) of this title and
not exempt under section 1003(b) of this title.
* * * * *
(b) Construction and application
* * * * *
(2)(A) Except as provided in subparagraph
(B), nothing in this subchapter shall be construed to
exempt or relieve any person from any law of any
State which regulates insurance, banking, or securi-
ties.
(B) Neither an employee benefit plan de-
scribed in section 1003(a) of this title, which is not
exempt under section 1003(b) of this title (other
than a plan established primarily for the purpose of
providing death benefits), nor any trust established
under such a plan, shall be deemed to be an insur-
2la
ance company or other insurer, bank, trust company,
or investment company or to be engaged in the
business of insurance or banking for purposes of any
law of any State purporting to regulate insurance
companies, insurance contracts, banks, trust compa-
nies, or investment companies.
* * * * *
TITLE 5—GOVERNMENT ORGANIZATION
AND EMPLOYEES
PART Il. EMPLOYEES
SUBPART G. INSURANCE AND ANNUITIES
CHAPTER 89. HEALTH INSURANCE
§ 8902. Contracting Authority
* * * ” *
(m)(1) The provisions of any contract under this
chapter which relate to the nature or extent of coverage
or benefits (including payments with respect to benefits)
shall supersede and preempt any State or local law, or
any regulation issued thereunder, which relates to health
insurance or plans to the extent that such law or regula-
tion is inconsistent with such contractual provisions.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.